Patent Assignment
Reel/Frame 073959/0198
Corrective Assignment to Correct the to Correct the Pct Patent Application Number from US2023/062319 to US2023/063219 Previously Recorded on Reel 72158 Frame 197. Assignor(S) Hereby Confirms the Assignment Recordation.
Recorded: 2025-09-15
Pages: 9
Assignor
CHIASMA (ISRAEL) LTD.
Executed: 2025-06-02
Assignee
AMYRT ENDO, INC.
160 FEDERAL STREET, 21ST FLOOR, BOSTON, MASSACHUSETTS, 02110
Covered Properties
(2)
Oral Octreotide for Treatment of Disease
Oral Octreotide for Treatment of Disease
Application:
63/313,909 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Sep 4, 2025
From: HAVIV, ASI
To: CHIASMA (ISRAEL) LTD.
Reel/Frame 072158/0163 →
Assignment of Assignor's Interest
Sep 4, 2025
From: CHIASMA (ISRAEL) LTD.
To: AMYRT ENDO, INC.
Reel/Frame 072158/0197 →
Corrective Assignment to Correct the to Correct the Pct Patent Application Number from US2023/062319 to US2023/063219 Previously Recorded on Reel 72158 Frame 163. Assignor(S) Hereby Confirms the Assignment Recordation.
Sep 15, 2025
From: HAVIV, ASI
To: CHIASMA (ISRAEL) LTD.
Reel/Frame 072805/0237 →
Merger and Change of Name
Jan 7, 2026
From: AMRYT ENDO, INC.; AMYRT PHARMACEUTICALS INC.
To: AMRYT PHARMACEUTICALS INC.
Reel/Frame 073389/0551 →